• Guest, the forum is undergoing some upgrades and so the usual themes will be unavailable for a few days. In the meantime, you can use the forum like normal. We'd love to know what you think about the forum! Take the 2025 Survey »

Type 2 Statins

My doctor says even when my cholesteral is normal, he still wants me to take statins, he says they have more benefits than just reducing cholesteral and says long term they prevent hardening of the arteries and i should take them. Has anyone else heard this ? what does eveybody think ?
 
Statins are known to thin the tendons. After being on 40mg atorvastatin for two years, my lipds are perfect. But I have achilles tendonitis in both ankles and can barely walk, and that, with considerable pain. Research it please. 25% chance with this statin to have tendonitis.
 
I didn't know about the tendons, but now know why when i was taking them, why i couldn't even lift my heels off the floor when standing.
 
My doctor says even when my cholesteral is normal, he still wants me to take statins, he says they have more benefits than just reducing cholesteral and says long term they prevent hardening of the arteries and i should take them. Has anyone else heard this ? what does eveybody think ?

 
My doctor says even when my cholesteral is normal, he still wants me to take statins, he says they have more benefits than just reducing cholesteral and says long term they prevent hardening of the arteries and i should take them. Has anyone else heard this ? what does eveybody think ?
It might be worth reading up on the HUNT2 study on over 50,000 Norwegians:


This was the conclusion:

Our study provides an updated epidemiological indication of possible errors in the CVD risk algorithms of many clinical guidelines. If our findings are generalizable, clinical and public health recommendations regarding the ‘dangers’ of cholesterol should be revised. This is especially true for women, for whom moderately elevated cholesterol (by current standards) may prove to be not only harmless but even beneficial.
 
It might be worth reading up on the HUNT2 study on over 50,000 Norwegians:


This was the conclusion:

Our study provides an updated epidemiological indication of possible errors in the CVD risk algorithms of many clinical guidelines. If our findings are generalizable, clinical and public health recommendations regarding the ‘dangers’ of cholesterol should be revised. This is especially true for women, for whom moderately elevated cholesterol (by current standards) may prove to be not only harmless but even beneficial.
And that was 2012. 11 yrs on and the recommendations have tightened not loosened.
 
Back
Top